MENU
KROS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Keros Therapeutics (KROS) Earnings Date & Reports
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs... Show more
A.I. Advisor
published Earnings
KROS is expected to report earnings to fall 35.20% to -93 cents per share on November 11
Q3'26
Est.
$-0.94
Q2'26
Missed
by $0.05
Q1'26
Missed
by $0.18
Q4'25
Missed
by $0.16
Q3'25
Beat
by $0.87
The last earnings report on August 03 showed earnings per share of -145 cents, missing the estimate of -139 cents. With 45.18K shares outstanding, the current market capitalization sits at 223.65M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on treatments for rare muscle diseases
Industry Biotechnology
Industry
N/A
Address
1050 Waltham Street
Phone
+1 617 314-6297
Employees
78
Web
https://www.kerostx.com